Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ: DXCM )

89.07 +4.98 (+5.92%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,591,968
Open 86.03
Bid (Size) 87.50 (3)
Ask (Size) 89.30 (7)
Prev. Close 84.09
Today's Range 86.00 - 89.84
52wk Range 62.34 - 142.00
Shares Outstanding 390,600,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's going on in today's session: S&P500 movers
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday. 
Via Chartmill
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts highlighted long-term growth potential. 
Via Benzinga

Performance

YTD
+13.46%
+13.46%
1 Month
+4.99%
+4.99%
3 Month
+16.78%
+16.78%
6 Month
+14.65%
+14.65%
1 Year
-23.90%
-23.90%

More News

Read More
In today's session, there are S&P500 stocks with remarkable trading volume.
Via Chartmill
Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What's Driving Markets Friday?
Via Benzinga
Topics Stocks
Exposures US Equities
DexCom Analysts Increase Their Forecasts After Q4 Earnings
Via Benzinga
Earnings Scheduled For February 13, 2025
Via Benzinga
Discover which S&P500 stocks are making waves on Friday.
Via Chartmill
Dexcom Q4 Earnings: Expanding Sales, New Products, Margin Pressure And More
Via Benzinga
DexCom (DXCM) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
DexCom: Revenue Up, EPS Misses Mark
Via The Motley Fool
DexCom’s (NASDAQ:DXCM) Q4: Beats On Revenue
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Should You Buy DexCom Stock Before Feb. 13?
Via The Motley Fool
Deep Dive Into DexCom Stock: Analyst Perspectives (5 Ratings)
Via Benzinga
Dexcom Tumbles As Fourth-Quarter Profit Lags Expectations
Via Investor's Business Daily
Dexcom Reports Fourth Quarter and Fiscal Year 2024 Financial Results
From DexCom, Inc.
Via Business Wire
DexCom (DXCM) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock?
Via Chartmill
Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade
Via The Motley Fool
Expert Outlook: DexCom Through The Eyes Of 11 Analysts
Via Benzinga
Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock?
Via Chartmill
Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years
Via The Motley Fool
For those who appreciate growth without the sticker shock, NASDAQ:DXCM is worth considering.
Via Chartmill
Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Lululemon To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
This Netflix Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.